3rd Quarter - Report

THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Disaster Planning/Emergencies DIS

Monitored issues related to the material threat list.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Budget/Appropriations BUD

Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and COVID-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE

Health Issues HCR

Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
DONALD KENT —

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.